Skip to Content
Diagnosed with severe psoriasis? Learn about biologics >>

Alcortin A Gel

Generic Name: hydrocortisone acetate, aloe vera leaf and iodoquinol
Dosage Form: gel

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Alcortin A Gel

ALCORTIN A- hydrocortisone acetate, aloe vera leaf and iodoquinol gel
Novum Pharma, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

ALCORTIN A® gel (2.0% Hydrocortisone Acetate, 1.0% Iodoquinol and 1.0% Aloe Polysaccharides)

Prescribing Information

Alcortin A Gel Description

Contents: Each gram of ALCORTIN A contains 2.0% (20 mg) Hydrocortisone Acetate, 1.0% (10 mg) Iodoquinol and 1.0% (10 mg) Aloe Polysaccharides. Other Ingredients: Purified Water, Carbopol, Magnesium Aluminum Silicate, PPG-20 Methyl Glucose Ether, Aminomethyl Propanol, Propylene Glycol, Glycerine, Benzyl Alcohol, SD Alcohol 40 B, Biopeptide, Hydrochloric Acid, FD&C Blue #1 and D&C Yellow #10.

Iodoquinol

Iodoquinol is an antifungal and antibacterial agent. Chemically, Iodoquinol is [5,7-diiodo-8-quinolinol] with the molecular formula (C9H5I2NO) and is represented by the following structural formula:

Slideshow: What's That? 10 Of The Most Common Skin Conditions

Hydrocortisone Acetate

Hydrocortisone Acetate is an anti-inflammatory and antipruritic agent. Chemically, Hydrocortisone Acetate is [Pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11, 17-dihydroxy-, (11ß)-] with the molecular formula (C23H32O6) and is represented by the following structural formula:

 

Aloe Polysaccharides

Aloe Polysaccharides are a concentrated, water soluble subcomponent of Aloe vera with a mono-sugar ratio of Man : Gal : Glc: 40 : 1.4 : 1.0, linkage of 1-4 β – linkage, O-Acetyl group of 25% of sugar units, and specific rotation of [α]D= -3.98° at 23.2 °C. Average molecular weight is 80,000 daltons. Chemically, Aloe Polysaccharides is represented by the following structural formula:

Alcortin A Gel - Clinical Pharmacology

Hydrocortisone Acetate has anti-inflammatory, antipruritic and vasoconstrictive properties. While the mechanism of anti-inflammatory activity is unclear, there is evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in humans. Iodoquinol has both antifungal and antibacterial properties.

Pharmacokinetics

The extent of percutaneous absorption of topical steroids is determined by many factors including the vehicle, the integrity of the epidermal barrier and the use of occlusive dressings. Hydrocortisone Acetate can be absorbed from normal intact skin. Inflammation and/or other inflammatory disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Once absorbed through the skin, Hydrocortisone Acetate is metabolized in the liver and most body tissue to hydrogenated and degraded forms such as tetrahydrocortisone and tetrahydrocortisol. These are excreted in the urine, mainly conjugated as glucuronides, together with a very small proportion of unchanged Hydrocortisone Acetate. There are no data available regarding the percutaneous absorption of Iodoquinol; however, following oral administration, 3-5% of the dose was recovered in the urine as a glucuronide.

Indications and Usage for Alcortin A Gel

Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: “Possibly” Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); monliasis; intertrigo. Final classification of the less-than-effective indications requires further investigation.

Contraindications

ALCORTIN A is contraindicated in those patients with a history of hypersensitivity to Hydrocortisone Acetate, Iodoquinol, aloe vera, glycine, histidine, lysine, palmitic acid or any other components of the preparation.  

Warnings and Precautions

For external use only. Keep away from eyes. If irritation develops, the use of ALCORTIN A should be discontinued and appropriate therapy instituted. Staining of the skin, hair and fabrics may occur. Not intended for use on infants or under diapers or occlusive dressings. If extensive areas are treated or if the occlusive dressing technique is used, the possibility exists of increased systemic absorption of the corticosteroid, and suitable precautions should be taken. Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity. Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings. Iodoquinol may be absorbed through the skin and interfere with thyroid function tests. If such tests are contemplated, wait at least one month after discontinuance of therapy to perform these tests. The ferric chloride test for phenylketonuria (PKU) can yield a false positive result if Iodoquinol is present in the diaper or urine. Prolonged use may result in overgrowth of non-susceptible organisms requiring appropriate therapy. Keep out of reach of children. Burning, itching, irritation and dryness have been reported infrequently following the use of topical corticosteroids.

Carcinogenesis, Mutagenesis and Impairment of Fertility:

Long term animal studies have not been performed to evaluate the carcinogenic potential of the effect on fertility of Hydrocortisone Acetate or Iodoquinol. In vitro studies to determine mutagenicity with Hydrocortisone Acetate have revealed negative results. Mutagenicity studies have not been performed with Iodoquinol.   

Pregnancy Category C:

Animal reproductive studies have not been conducted with ALCORTIN A. It is not known whether ALCORTIN A can cause fetal harm when administered to pregnant women or can affect reproductive capacity. ALCORTIN A should be given to pregnant women only if clearly needed.  

Nursing Mothers:

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when ALCORTIN A is administered to a nursing woman. 

Pediatric Use:

Safety and effectiveness in pediatric patients under the age of 12 have not been established.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence. Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.

Alcortin A Gel Dosage and Administration

Apply to affected areas 3-4 times daily or as directed by a physician. Follow your physician’s directions regarding length of treatment after symptoms resolve.

How is Alcortin A Gel Supplied

NDC # 69646-705-15: 48 gram tube 
NDC # 69646-705-13: 48 gram carton of 24-count of 2 gram gel individual packs
NDC # 69646-705-02: 2 gram gel individual pack, not intended for sale separately
NDC # 69646-705-08: 10-count carton of 2 gram gel sample packs - not for resale

Each 2 gram gel pack contains multiple doses depending on the surface area treated.

STORAGE

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Keep tightly closed. Rx only.

Manufactured for and distributed by:                        
Novum Pharma, LLC                        
Chicago, IL 60654

U.S. Patents #6,436,679; #6,271,214; #6,133,440; #5,925,357; #5,902,796; #5,708,038; #5,703,060; #5,468,737 other patents pending.

© 2015 Novum Pharma, LLC. All rights reserved.             ISS. 0315 #00499

PRINCIPAL DISPLAY PANEL

NDC 69646-705-15
Alcortin A
1% iodoquinol- 2% hydrocortisone acetate
1% aloe polysaccharides

Rx Only

Net Wt. 48 g (1.69 oz.)

ALCORTIN A 
iodoquinol, hydrocortisone acetate and aloe vera leaf gel
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:69646-705
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
IODOQUINOL (IODOQUINOL) IODOQUINOL 10 mg  in 1 g
HYDROCORTISONE ACETATE (HYDROCORTISONE) HYDROCORTISONE ACETATE 20 mg  in 1 g
ALOE VERA LEAF (ALOE VERA LEAF) ALOE VERA LEAF 10 mg  in 1 g
Inactive Ingredients
Ingredient Name Strength
WATER  
MAGNESIUM ALUMINUM SILICATE  
PPG-20 METHYL GLUCOSE ETHER  
AMINOMETHYLPROPANOL  
PROPYLENE GLYCOL  
GLYCERIN  
BENZYL ALCOHOL  
HYDROCHLORIC ACID  
FD&C BLUE NO. 1  
D&C YELLOW NO. 10  
Packaging
# Item Code Package Description
1 NDC:69646-705-08 10 PACKET in 1 CARTON
1 2 g in 1 PACKET
2 NDC:69646-705-13 24 PACKET in 1 CARTON
2 2 g in 1 PACKET
3 NDC:69646-705-02 2 g in 1 PACKET
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 03/01/2015
Labeler - Novum Pharma, LLC (079736743)
Revised: 03/2015
 
Novum Pharma, LLC

More about Alcortin A (aloe vera / hydrocortisone / iodoquinol topical)

Consumer resources

Related treatment guides

Hide